spacer
home > ict > autumn 2016 > communication is key
PUBLICATIONS
International Clinical Trials

Communication is Key

ICT: This year’s spotlight at the Partnerships in Clinical Trials (PCT) Europe event is on patient centricity. In your opinion, what are the main challenges in recruiting and retaining subjects today, and what can be done to improve this often labour-intensive and costly task?

Naomi Brooker: While researching with industry professionals, it appears that one of the fundamental issues lies within how we are communicating – patients don’t want to feel like guinea pigs that are being experimented on. The general public perception is that clinical trials can be risky, and this can be off-putting; after all, they generally only see the disasters in the news, not the many success stories that arise from trials. In particular, some patients worry that they could be given a placebo that could be detrimental to their health, while others are concerned that companies are more interested in profit than helping them recover; others decided that the risk factor was too great.

To remove this underlying fear, communication is key and marketing campaigns, as well as patient advocates, can play a pivotal role. What are you, as a company, doing to ensure that patients feel valued? How are they engaged with? Are they treated as a number or a person? These are the real questions that can make a difference.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Naomi Brooker is the Conference Director of PCT Europe, developing the event in partnership with their advisory board. Since completing a BSc at UCL, UK, in Biomedical Science and a Law Conversion at BBP Law School, UK, she has been researching key trends and current challenges with various industry sectors such as pharma and agrochemical, most recently focusing on clinical trials.
spacer
Naomi Brooker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Launches ADC ExpressTM Services to Accelerate Pre-clinical Conjugation Candidate Selection

• Provides rapid production of antibody drug conjugates (ADCs) for best candidate selection • Established platform technology to reliably scale target molecules • Reduces time to clinic through comprehensive ADC services from pre-clinical to commercial from a single source
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement